JP2018535203A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018535203A5 JP2018535203A5 JP2018520089A JP2018520089A JP2018535203A5 JP 2018535203 A5 JP2018535203 A5 JP 2018535203A5 JP 2018520089 A JP2018520089 A JP 2018520089A JP 2018520089 A JP2018520089 A JP 2018520089A JP 2018535203 A5 JP2018535203 A5 JP 2018535203A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- group
- compound according
- iron
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)(*C(C)(*)N(*)C(C1*=*(*N(*)*c2nc(C=CC(C)(*)C=C3)c3[n]2)*=*1)=O)C1=NC=CC(C)(*)C=C1 Chemical compound CC(C)(*C(C)(*)N(*)C(C1*=*(*N(*)*c2nc(C=CC(C)(*)C=C3)c3[n]2)*=*1)=O)C1=NC=CC(C)(*)C=C1 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020091830A JP6967112B2 (ja) | 2015-10-23 | 2020-05-27 | 新規なフェロポーチン阻害剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15191176 | 2015-10-23 | ||
| EP15191176.5 | 2015-10-23 | ||
| EP15191179 | 2015-10-23 | ||
| EP15191179.9 | 2015-10-23 | ||
| PCT/EP2016/075306 WO2017068090A1 (en) | 2015-10-23 | 2016-10-21 | Novel ferroportin inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020091830A Division JP6967112B2 (ja) | 2015-10-23 | 2020-05-27 | 新規なフェロポーチン阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018535203A JP2018535203A (ja) | 2018-11-29 |
| JP2018535203A5 true JP2018535203A5 (cg-RX-API-DMAC7.html) | 2019-03-14 |
| JP6710754B2 JP6710754B2 (ja) | 2020-06-17 |
Family
ID=57178421
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018520090A Active JP6810988B2 (ja) | 2015-10-23 | 2016-10-21 | 新規なフェロポーチン阻害剤 |
| JP2018520089A Active JP6710754B2 (ja) | 2015-10-23 | 2016-10-21 | 新規なフェロポーチン阻害剤 |
| JP2020091830A Active JP6967112B2 (ja) | 2015-10-23 | 2020-05-27 | 新規なフェロポーチン阻害剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018520090A Active JP6810988B2 (ja) | 2015-10-23 | 2016-10-21 | 新規なフェロポーチン阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020091830A Active JP6967112B2 (ja) | 2015-10-23 | 2020-05-27 | 新規なフェロポーチン阻害剤 |
Country Status (30)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2968443T1 (sl) | 2013-03-15 | 2022-01-31 | Protagonist Therapeutics, Inc. | Analogi hepcidina in njihova uporaba |
| EP3365339B1 (en) | 2015-10-23 | 2025-07-16 | Vifor (International) AG | Novel ferroportin inhibitors |
| JOP20180036A1 (ar) * | 2017-04-18 | 2019-01-30 | Vifor Int Ag | أملاح لمثبطات فروبورتين جديدة |
| CN108314687A (zh) * | 2017-12-27 | 2018-07-24 | 重庆文理学院 | 1,2-二氢苯并[4,5]咪唑并[1,2-a]吡嗪-3（4H）-酮衍生物的合成 |
| EP4501952A3 (en) | 2018-02-08 | 2025-04-16 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| EP3788065B1 (en) | 2018-04-30 | 2025-08-27 | The Children's Hospital Of Philadelphia | Improving anemias by combining agents |
| EP3894416B1 (en) | 2018-12-13 | 2022-11-09 | Global Blood Therapeutics, Inc. | Ferroportin inhibitors and methods of use |
| TW202102478A (zh) | 2019-04-01 | 2021-01-16 | 瑞士商威佛（國際）股份有限公司 | 新穎的鐵螯合物 |
| AU2020317631B2 (en) * | 2019-07-19 | 2025-09-18 | Vifor (International) Ag | Ferroportin-inhibitors for the use in the prevention and treatment of kidney injuries |
| US20220273634A1 (en) * | 2019-07-19 | 2022-09-01 | Vifor (International) Ag | Ferroportin-Inhibitors For The Use In The Treatment Of Transfusion-Dependent Beta-Thalassemia (TDT) |
| EP3782702A1 (en) * | 2019-08-21 | 2021-02-24 | AC BioScience SA | Compounds and use thereof for the treatment of infectious diseases and cancer |
| BR112022003999A2 (pt) | 2019-09-03 | 2022-05-31 | Protagonist Therapeutics Inc | Miméticos de hepcidina conjugados |
| CN114765955B (zh) | 2019-10-22 | 2025-06-24 | 威佛（国际）股份公司 | 用铁转运蛋白抑制剂(vit-2763)治疗镰状细胞病的方法和组合物 |
| CA3172806A1 (en) * | 2020-03-24 | 2021-09-30 | Stefan Reim | Process for the production of ferroportin inhibitors |
| GB202012969D0 (en) * | 2020-08-19 | 2020-09-30 | Univ Of Oxford | Inhibitor compounds |
| EP4281072A1 (en) | 2021-01-20 | 2023-11-29 | Vifor (International) Ag | Ferroportin-inhibitors for the use in the treatment of myelodysplastic syndromes (mds) |
| WO2022173818A1 (en) * | 2021-02-09 | 2022-08-18 | University Of Virginia Patent Foundation | Use of biliverdin reductase b inhibitors to allow malaria eradication in patients with g6pd deficiency |
| RS67088B1 (sr) * | 2021-03-26 | 2025-09-30 | Chiesi Farm Spa | Derivati tetrahidrotienopiridina kao inhibitori ddr |
| TW202304896A (zh) * | 2021-04-22 | 2023-02-01 | 瑞士商威佛（國際）股份有限公司 | 經修飾的膜鐵運輸蛋白(ferroportin)抑制劑 |
| TW202312996A (zh) | 2021-09-21 | 2023-04-01 | 瑞士商威佛（國際）股份有限公司 | N取代的膜鐵運輸蛋白(ferroportin)抑制劑 |
| JP2025535398A (ja) | 2022-10-21 | 2025-10-24 | ビフォー （インターナショナル） エージー | 二環式フェロポーチン阻害剤 |
| CN115974864B (zh) * | 2022-12-29 | 2025-09-16 | 苏州汉德创宏生化科技有限公司 | 一种2-(3-氮杂环丁基)噻唑盐的合成方法 |
| WO2024200512A1 (en) | 2023-03-27 | 2024-10-03 | Silence Therapeutics Gmbh | Compounds and compositions for use in stem cell transplantation |
| WO2025003139A1 (en) | 2023-06-26 | 2025-01-02 | Vifor (International) Ag | Ferroportin-inhibitors for the use in the treatment of hereditary haemochromatosis (hh) |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB937879A (en) | 1959-12-24 | 1963-09-25 | Ciba Ltd | New pyrazole-carboxylic acid hydrazides |
| CH479616A (de) * | 1959-12-24 | 1969-10-15 | Ciba Geigy | Verfahren zur Herstellung neuer Methylidenverbindungen |
| TW533205B (en) | 1996-06-25 | 2003-05-21 | Novartis Ag | Substituted 3,5-diphenyl-l,2,4-triazoles and their pharmaceutical composition |
| US5922761A (en) | 1996-09-06 | 1999-07-13 | Medinox, Inc. | Methods for in vivo reduction of iron levels and compositions useful therefor |
| PE27799A1 (es) | 1996-12-10 | 1999-03-18 | Novartis Ag | Formulaciones y formas polimorficas de desferrioxamina y su preparacion |
| JP2001505585A (ja) * | 1996-12-16 | 2001-04-24 | 藤沢薬品工業株式会社 | 新規アミド化合物およびそれらの一酸化窒素シンターゼ阻害剤としての用途 |
| EP1169311A4 (en) | 1999-03-22 | 2004-09-15 | Rhode Island Education | COMBINATORIAL OXAZOLE AND THIAZOLE BANKS |
| EP1072265A1 (en) | 1999-07-20 | 2001-01-31 | MEDIS S.r.l. Medical Infusion Systems | Use of plant polyphenols for treating iron overload |
| EP1074254A3 (en) | 1999-07-20 | 2002-09-11 | MEDIS S.r.l. Medical Infusion Systems | Use of plant polyphenols with vitamines for treating iron overload |
| WO2002022599A2 (en) * | 2000-09-15 | 2002-03-21 | Anormed Inc. | Chemokine receptor binding heterocyclic compounds |
| DE10063173A1 (de) * | 2000-12-18 | 2002-06-20 | Merck Patent Gmbh | Harnstoff- und Urethanderivate |
| CA2461603A1 (en) * | 2001-09-24 | 2003-04-03 | Elan Pharmaceuticals, Inc. | Substituted amines for the treatment of neurological disorders |
| US20030109548A1 (en) | 2001-11-09 | 2003-06-12 | Royt Paulette W. | Compositions and methods of treating iron excess |
| US6933308B2 (en) | 2002-12-20 | 2005-08-23 | Bristol-Myers Squibb Company | Aminoalkyl thiazole derivatives as KCNQ modulators |
| WO2005011685A1 (en) | 2003-07-21 | 2005-02-10 | Applied Research Systems Ars Holding N.V. | Aryl dicarboxamides |
| WO2005014576A1 (ja) | 2003-08-12 | 2005-02-17 | Takeda Pharmaceutical Company Limited | イソキノリノン誘導体、その製造法および用途 |
| DE10356409B4 (de) | 2003-11-28 | 2006-12-28 | Biofrontera Discovery Gmbh | Neues Arzneimittel Oxachelin und Derivate |
| FR2870271B1 (fr) | 2004-05-11 | 2008-03-14 | Bruno Merand | Procede de construction d'une maison en bois et moyens pour la mise en oeuvre du procede. |
| WO2006004841A2 (en) * | 2004-06-29 | 2006-01-12 | The Scripps Research Institute | Galanin agonists |
| WO2006040646A1 (en) | 2004-10-14 | 2006-04-20 | Pfizer, Inc. | Benzimidazole or indole amides as inhibitors of pin1 |
| JP2008007405A (ja) | 2004-12-07 | 2008-01-17 | Takeda Chem Ind Ltd | カルボキサミド誘導体 |
| EP2335719B1 (en) * | 2005-02-16 | 2015-06-24 | The General Hospital Corporation | Use of hemojuvelin fusion proteins to regulate hepcidin-mediated iron metabolism |
| US20060252807A1 (en) | 2005-04-22 | 2006-11-09 | Kalypsys, Inc. | Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders |
| CA2609203A1 (en) | 2005-05-23 | 2006-11-30 | Merck & Co., Inc | Proline bis-amide orexin receptor antagonists |
| WO2006132436A1 (ja) * | 2005-06-08 | 2006-12-14 | Japan Tobacco Inc. | 複素環化合物 |
| US7446195B2 (en) * | 2005-08-17 | 2008-11-04 | Schering Corporation | High affinity thiophene-based and furan-based kinase ligands |
| AU2006316087B2 (en) | 2005-11-21 | 2011-03-10 | Shionogi & Co., Ltd. | Heterocyclic compound having inhibitory activity on 11-beta-hydroxysteroid dehydrogenase type I |
| WO2007084390A2 (en) * | 2006-01-13 | 2007-07-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| EP2132178B1 (en) | 2006-12-20 | 2015-08-19 | Merck Sharp & Dohme Corp. | Jnk inhibitors |
| AR065628A1 (es) | 2007-03-07 | 2009-06-17 | Xenon Pharmaceuticals Inc | Compuestos triciclicos de utilidad en el tratamiento de trastornos por carencia de hierro en el organismo |
| AR065785A1 (es) | 2007-03-19 | 2009-07-01 | Xenon Pharmaceuticals Inc | Compuestos biarilo y biheteroarilo de utilidad en el tratamiento de trastornos de hierro |
| US20100093871A1 (en) | 2007-03-20 | 2010-04-15 | Meiji Seika Kaisha, Ltd. | Agent for prevention or treatment of iron overload disorders |
| CL2008000793A1 (es) | 2007-03-23 | 2008-05-30 | Xenon Pharmaceuticals Inc | Compuestos derivados de dihidroindazol; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno del hierro. |
| WO2008117862A1 (ja) * | 2007-03-28 | 2008-10-02 | Santen Pharmaceutical Co., Ltd. | ウレア構造を有する新規ピリジンカルボン酸（２－アミノフェニル）アミド誘導体 |
| CA2688547A1 (en) | 2007-06-05 | 2008-12-11 | Xenon Pharmaceuticals, Inc. | Aromatic and heteroaromatic compounds useful in treating iron disorders |
| US20120094974A1 (en) | 2008-06-17 | 2012-04-19 | Wei Chen | Smoothened receptor modulators |
| WO2010020556A1 (en) | 2008-08-22 | 2010-02-25 | Evotec Neurosciences Gmbh | New bradykinin b1 antagonists |
| KR20110060904A (ko) | 2008-09-26 | 2011-06-08 | 베링거 인겔하임 인터내셔날 게엠베하 | Ｃｃｒ1 수용체 길항제로서의 아자인다졸 화합물 |
| EP2370424A1 (en) * | 2008-11-10 | 2011-10-05 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| EP2346853A2 (en) | 2008-11-19 | 2011-07-27 | Schering Corporation | Inhibitors of diacylglycerol acyltransferase |
| CA2748274A1 (en) | 2008-12-30 | 2010-07-08 | Millennium Pharmaceuticals, Inc. | Heteroaryl compounds useful as raf kinase inhibitors |
| AR077958A1 (es) | 2009-08-27 | 2011-10-05 | Vifor Int Ag | Quinoxalinonas antagonistas de la hepcidina |
| TW201111379A (en) * | 2009-09-09 | 2011-04-01 | Vifor Int Ag | Novel thiazole-and oxazole-hepcidine-antagonists |
| EP2516424B1 (en) * | 2009-12-22 | 2013-12-18 | Syngenta Participations AG | Pyrazole derivatives |
| AU2012334804B2 (en) | 2011-11-07 | 2016-12-15 | The University Of Queensland | Modulators of C3a receptors |
| HK1199892A1 (en) | 2011-12-09 | 2015-07-24 | The Regents Of The University Of California | Modified mini-hepcidin peptides and methods of using thereof |
| EP2620142A1 (en) * | 2012-01-27 | 2013-07-31 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Hedgehog signaling pathway involved in energy metabolism |
| AU2013235491A1 (en) | 2012-03-22 | 2014-09-11 | Nanotherapeutics, Inc. | Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles |
| MX2014013734A (es) * | 2012-05-11 | 2015-06-10 | Abbvie Inc | Inhibidores de nampt. |
| CN103508957B (zh) | 2012-06-25 | 2017-02-08 | 中国科学院上海药物研究所 | 羟乙基吡唑类化合物或氨乙基吡唑类化合物及其制备方法和用途 |
| EP3348280A1 (en) * | 2012-07-12 | 2018-07-18 | Hangzhou Dac Biotech Co., Ltd | Conjugates of cell binding molecules with cytotoxic agents |
| AR097279A1 (es) * | 2013-08-09 | 2016-03-02 | Actelion Pharmaceuticals Ltd | Derivados de benzimidazolil-metil urea como agonistas del receptor de alx |
| WO2015051362A1 (en) | 2013-10-04 | 2015-04-09 | Illinois Institute Of Technology | Multifunctional chelators, complexes, and compositions thereof, and methods of using same |
| WO2015069660A2 (en) | 2013-11-05 | 2015-05-14 | New York Blood Center, Inc. | Methods and compositions for increasing hepcidin expression using modified iron binding/releasing transferrin |
| AU2014352780A1 (en) * | 2013-11-22 | 2016-06-09 | University Of Florida Research Foundation, Inc. | Desferrithiocin analogs and uses thereof |
| CN107249580A (zh) * | 2014-12-05 | 2017-10-13 | An2H探索有限公司 | 帕金连接酶活化方法和组合物 |
| EP3365339B1 (en) * | 2015-10-23 | 2025-07-16 | Vifor (International) AG | Novel ferroportin inhibitors |
-
2016
- 2016-10-21 EP EP16797462.5A patent/EP3365339B1/en active Active
- 2016-10-21 PL PL16797462.5T patent/PL3365339T3/pl unknown
- 2016-10-21 AU AU2016342309A patent/AU2016342309B2/en active Active
- 2016-10-21 SG SG11201802665VA patent/SG11201802665VA/en unknown
- 2016-10-21 EP EP16784510.6A patent/EP3364967A2/en active Pending
- 2016-10-21 SG SG11201802480YA patent/SG11201802480YA/en unknown
- 2016-10-21 ES ES16797462T patent/ES3039644T3/es active Active
- 2016-10-21 RS RS20251013A patent/RS67304B1/sr unknown
- 2016-10-21 JP JP2018520090A patent/JP6810988B2/ja active Active
- 2016-10-21 WO PCT/EP2016/075305 patent/WO2017068089A2/en not_active Ceased
- 2016-10-21 SM SM20250391T patent/SMT202500391T1/it unknown
- 2016-10-21 SG SG10202005377VA patent/SG10202005377VA/en unknown
- 2016-10-21 JP JP2018520089A patent/JP6710754B2/ja active Active
- 2016-10-21 WO PCT/EP2016/075306 patent/WO2017068090A1/en not_active Ceased
- 2016-10-21 CA CA3002418A patent/CA3002418C/en active Active
- 2016-10-21 CN CN202210353448.6A patent/CN114668761B/zh active Active
- 2016-10-21 HR HRP20251038TT patent/HRP20251038T1/hr unknown
- 2016-10-21 MA MA44474A patent/MA44474B1/fr unknown
- 2016-10-21 PE PE2018000572A patent/PE20181496A1/es unknown
- 2016-10-21 US US15/769,148 patent/US10364239B2/en active Active
- 2016-10-21 PT PT167974625T patent/PT3365339T/pt unknown
- 2016-10-21 AU AU2016342310A patent/AU2016342310B2/en active Active
- 2016-10-21 BR BR112018007977-4A patent/BR112018007977B1/pt active IP Right Grant
- 2016-10-21 US US15/768,025 patent/US10738041B2/en active Active
- 2016-10-21 TW TW105134089A patent/TWI722031B/zh active
- 2016-10-21 MY MYPI2018000549A patent/MY198246A/en unknown
- 2016-10-21 DK DK16797462.5T patent/DK3365339T3/da active
- 2016-10-21 MX MX2018004882A patent/MX390514B/es unknown
- 2016-10-21 CO CONC2018/0004165A patent/CO2018004165A2/es unknown
- 2016-10-21 LT LTEPPCT/EP2016/075306T patent/LT3365339T/lt unknown
- 2016-10-21 KR KR1020187011524A patent/KR102352829B1/ko active Active
- 2016-10-21 UA UAA201805740A patent/UA123219C2/uk unknown
- 2016-10-21 FI FIEP16797462.5T patent/FI3365339T3/fi active
- 2016-10-21 CN CN201680061941.3A patent/CN108290878B/zh active Active
- 2016-10-21 CA CA3002416A patent/CA3002416C/en active Active
- 2016-10-23 JO JOP/2016/0229A patent/JO3780B1/ar active
-
2018
- 2018-03-15 IL IL258158A patent/IL258158B2/en unknown
- 2018-03-15 IL IL258159A patent/IL258159B/en unknown
- 2018-04-06 PH PH12018500769A patent/PH12018500769A1/en unknown
- 2018-04-20 MX MX2021015106A patent/MX2021015106A/es unknown
- 2018-04-20 CL CL2018001031A patent/CL2018001031A1/es unknown
-
2019
- 2019-06-12 US US16/438,596 patent/US11001579B2/en active Active
-
2020
- 2020-05-27 JP JP2020091830A patent/JP6967112B2/ja active Active
- 2020-11-24 AU AU2020277121A patent/AU2020277121C1/en active Active
- 2020-12-03 US US17/110,465 patent/US11066399B2/en active Active
-
2021
- 2021-06-07 US US17/340,692 patent/US20220363675A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018535203A5 (cg-RX-API-DMAC7.html) | ||
| JP2018536641A5 (cg-RX-API-DMAC7.html) | ||
| HRP20251038T1 (hr) | Novi inhibitori feroportina | |
| AU2014251087B2 (en) | Formulations of oxabicycloheptanes and oxabicycloheptenes | |
| KR102283895B1 (ko) | 제약 조합물 | |
| JP2019517487A5 (cg-RX-API-DMAC7.html) | ||
| EP4442241A3 (en) | Retinol replacement in skin treatment | |
| JP2014511892A5 (cg-RX-API-DMAC7.html) | ||
| RU2013108865A (ru) | Производные хинолина и содержащие их ингибиторы melk | |
| JP2009538897A5 (cg-RX-API-DMAC7.html) | ||
| JP2013526559A5 (cg-RX-API-DMAC7.html) | ||
| TW201422567A (zh) | 多環化合物與其製造及使用方法 | |
| WO2014026039A4 (en) | Aryl-and heteroaryl-substituted benzene derivatives as modulators of pi3-kinase signalling pathways | |
| CR20220196A (es) | Inhibidores del factor d del complemento para administración oral | |
| JP2016515550A5 (cg-RX-API-DMAC7.html) | ||
| ZA202203107B (en) | Azaindole carboxamide compounds for the treatment of mycobacterial infections | |
| PH12021550878A1 (en) | Cyclodextrin-based formulation of a bcl-2 inhibitor | |
| JP2017515857A5 (cg-RX-API-DMAC7.html) | ||
| RU2013136045A (ru) | Ингибиторы каспазы-2 | |
| EP1689405B1 (en) | Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance | |
| FR3056108A1 (fr) | Utilisation des harringtonines dans le traitement cancer du sein, notamment triple-negatif | |
| JP2021501133A5 (cg-RX-API-DMAC7.html) | ||
| JP2017530132A5 (cg-RX-API-DMAC7.html) | ||
| AU2016277929B2 (en) | Combination therapy using belinostat and pralatrexate to treat lymphoma | |
| RU2024110708A (ru) | N-замещенные ингибиторы ферропортина |